These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38502703)

  • 1. Mimicking angiogenic microenvironment of alveolar soft-part sarcoma in a microfluidic coculture vasculature chip.
    Chuaychob S; Lyu R; Tanaka M; Haginiwa A; Kitada A; Nakamura T; Yokokawa R
    Proc Natl Acad Sci U S A; 2024 Mar; 121(13):e2312472121. PubMed ID: 38502703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structured myeloid cells and anti-angiogenic therapy in alveolar soft part sarcoma.
    Castelli C; Tazzari M; Negri T; Vergani B; Rivoltini L; Stacchiotti S; Pilotti S
    J Transl Med; 2013 Sep; 11():237. PubMed ID: 24074204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis, Prognosis, and Treatment of Alveolar Soft-Part Sarcoma: A Review.
    Paoluzzi L; Maki RG
    JAMA Oncol; 2019 Feb; 5(2):254-260. PubMed ID: 30347044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Alveolar Soft Part Sarcoma-The Angiogenic Mechanism Regulated by a Fusion Gene Product].
    Nakamura T; Tanaka M
    Gan To Kagaku Ryoho; 2024 Jun; 51(6):585-590. PubMed ID: 39009511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Landscape in Alveolar Soft Part Sarcoma: Implications for Molecular Targeted Therapy.
    Soheilifar MH; Taheri RA; Zolfaghari Emameh R; Moshtaghian A; Kooshki H; Motie MR
    Biomed Pharmacother; 2018 Jul; 103():889-896. PubMed ID: 29710505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain Metastases and Place of Antiangiogenic Therapies in Alveolar Soft Part Sarcoma: A Retrospective Analysis of the French Sarcoma Group.
    Malouf GG; Beinse G; Adam J; Mir O; Chamseddine AN; Terrier P; Honore C; Spano JP; Italiano A; Kurtz JE; Coindre JM; Blay JY; Le Cesne A
    Oncologist; 2019 Jul; 24(7):980-988. PubMed ID: 30626710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ASPSCR1::TFE3 orchestrates the angiogenic program of alveolar soft part sarcoma.
    Tanaka M; Chuaychob S; Homme M; Yamazaki Y; Lyu R; Yamashita K; Ae K; Matsumoto S; Kumegawa K; Maruyama R; Qu W; Miyagi Y; Yokokawa R; Nakamura T
    Nat Commun; 2023 Apr; 14(1):1957. PubMed ID: 37029109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cabozantinib and dastinib exert anti-tumor activity in alveolar soft part sarcoma.
    Mukaihara K; Tanabe Y; Kubota D; Akaike K; Hayashi T; Mogushi K; Hosoya M; Sato S; Kobayashi E; Okubo T; Kim Y; Kohsaka S; Saito T; Kaneko K; Suehara Y
    PLoS One; 2017; 12(9):e0185321. PubMed ID: 28945796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling Alveolar Soft Part Sarcoma Unveils Novel Mechanisms of Metastasis.
    Tanaka M; Homme M; Yamazaki Y; Shimizu R; Takazawa Y; Nakamura T
    Cancer Res; 2017 Feb; 77(4):897-907. PubMed ID: 27979841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. iCREATE: imaging features of primary and metastatic alveolar soft part sarcoma from the EORTC CREATE study.
    Mcaddy NC; Saffar H; Litière S; Jespers P; Schöffski P; Messiou C
    Cancer Imaging; 2020 Oct; 20(1):79. PubMed ID: 33121537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammalian target of rapamycin pathway activity in alveolar soft part sarcoma.
    Reis H; Hager T; Wohlschlaeger J; Bauer S; Katenkamp K; Katenkamp D; Baba HA
    Hum Pathol; 2013 Oct; 44(10):2266-74. PubMed ID: 23871289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomics, Morphoproteomics, and Treatment Patterns of Patients with Alveolar Soft Part Sarcoma and Response to Multiple Experimental Therapies.
    Groisberg R; Roszik J; Conley AP; Lazar AJ; Portal DE; Hong DS; Naing A; Herzog CE; Somaiah N; Zarzour MA; Patel S; Brown RE; Subbiah V
    Mol Cancer Ther; 2020 May; 19(5):1165-1172. PubMed ID: 32127467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of Pazopanib and Trabectedin in Advanced Alveolar Soft Part Sarcoma.
    Stacchiotti S; Mir O; Le Cesne A; Vincenzi B; Fedenko A; Maki RG; Somaiah N; Patel S; Brahmi M; Blay JY; Boye K; Sundby Hall K; Gelderblom H; Hindi N; Martin-Broto J; Kosela H; Rutkowski P; Italiano A; Duffaud F; Kobayashi E; Casali PG; Provenzano S; Kawai A
    Oncologist; 2018 Jan; 23(1):62-70. PubMed ID: 28754721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment and characterization of NCC-ASPS2-C1: a novel patient-derived cell line of alveolar soft part sarcoma.
    Osaki J; Noguchi R; Yanagihara K; Ono T; Adachi Y; Iwata S; Toda Y; Sekita T; Kobayashi E; Kojima N; Yoshida A; Kawai A; Kondo T
    Hum Cell; 2024 May; 37(3):865-873. PubMed ID: 38478355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ASPS-1, a novel cell line manifesting key features of alveolar soft part sarcoma.
    Kenney S; Vistica DT; Stockwin LH; Burkett S; Hollingshead MG; Borgel SD; Butcher DO; Schrump DS; Shoemaker RH
    J Pediatr Hematol Oncol; 2011 Jul; 33(5):360-8. PubMed ID: 21552147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenesis-promoting gene patterns in alveolar soft part sarcoma.
    Lazar AJ; Das P; Tuvin D; Korchin B; Zhu Q; Jin Z; Warneke CL; Zhang PS; Hernandez V; Lopez-Terrada D; Pisters PW; Pollock RE; Lev D
    Clin Cancer Res; 2007 Dec; 13(24):7314-21. PubMed ID: 18094412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alveolar soft part sarcoma: progress toward improvement in survival? A population-based study.
    Fujiwara T; Nakata E; Kunisada T; Ozaki T; Kawai A
    BMC Cancer; 2022 Aug; 22(1):891. PubMed ID: 35971085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of Immunological and Molecular Profiles with Response to Crizotinib in Alveolar Soft Part Sarcoma: An Exploratory Study Related to the EORTC 90101 "CREATE" Trial.
    Lee CJ; Modave E; Boeckx B; Kasper B; Aamdal S; Leahy MG; Rutkowski P; Bauer S; Debiec-Rychter M; Sciot R; Lambrechts D; Wozniak A; Schöffski P
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel therapeutic options for alveolar soft part sarcoma: antiangiogenic therapy, immunotherapy and beyond.
    Brahmi M; Vanacker H; Dufresne A
    Curr Opin Oncol; 2020 Jul; 32(4):295-300. PubMed ID: 32541316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling alveolar soft part sarcomagenesis in the mouse: a role for lactate in the tumor microenvironment.
    Goodwin ML; Jin H; Straessler K; Smith-Fry K; Zhu JF; Monument MJ; Grossmann A; Randall RL; Capecchi MR; Jones KB
    Cancer Cell; 2014 Dec; 26(6):851-862. PubMed ID: 25453902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.